NNM Securities

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila

BSE947.90-5.6 (-0.59 %)

PREV CLOSE ( ) 953.50

OPEN PRICE ( ) 951.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 24168

TODAY'S LOW / HIGH ( )945.00 958.00

52 WK LOW / HIGH ( )482.55 1031.3

NSE947.40-3.85 (-0.4 %)

PREV CLOSE( ) 951.25

OPEN PRICE ( ) 951.50

BID PRICE (QTY) 947.40 (334)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 697528

TODAY'S LOW / HIGH( ) 944.50 958.65

52 WK LOW / HIGH ( )484.95 1031.7

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995

Management Info

Pankaj R Patel - Chairman Sharvil P Patel - Managing Director

Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079-71800000 / 48040000

Email dhavalsoni@zyduscadila.com

Website www.zyduscadila.com

Registrars Details

Link Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE, MCX

NEWS

26Apr Zydus Lifesciences gets USFDA’s final
Zydus Lifesciences has received final approval from the United States Fo..

24Apr USFDA concludes inspection at Zydus Li
United States Food and Drug Administration (USFDA) has concluded the ins..

24Apr Zydus Lifesciences informs about discl
Zydus Lifesciences has informed that the USFDA conducted an inspection a..

23Apr Zydus Lifesciences gets nod for new dr
Zydus Lifesciences has received approval from National Medical Products..

23Apr Zydus Lifesciences edges higher on get
Zydus Lifesciences is currently trading at Rs. 960.45, up by 1.00 points..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	4504	15292
Gross Profit	5743	20322
Operating Profit	8059	30028
Net Sales	23713	87316

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE) 4025.35 (4.81%)	M.Cap (Rs. in Cr)106860.39
Sanofi India (BSE) 8278.10 (1.76%)	M.Cap (Rs. in Cr)19064.98
Abbott India (BSE) 25864.85 (0.54%)	M.Cap (Rs. in Cr)54961.00
Astrazeneca Pharma I (BSE) 5415.40 (2.18%)	M.Cap (Rs. in Cr)13538.50
Glaxosmithkline Phar (BSE) 2132.75 (3.26%)	M.Cap (Rs. in Cr)36130.07

Shareholding Pattern

	PROMOTERS	74.98%
	MUTUAL FUNDS/UTI	6.71%
	NON-INSTITUTION	6.66%
	FI/BANKS/INSURANCE	5.74%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
LIC MF Healthcare F...	7.46
Kotak Healthcare Fu...	6.35
Tata India Pharma &...	5.40
Aditya Birla SL Pha...	4.46
Nippon India Pharma...	4.18
360 ONE Quant Fund-Reg(G)	3.95
ICICI Pru Nifty Pha...	3.91

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

ZYDUS LIFESCIENCES LTD.

Filing compliant on SCORES – Easy & quick